Sign in
IDXG Stock Price, Chart, Stats & News
Interpace Biosciences, Inc.
Save
Interpace Biosciences, Inc. (IDXG) does not currently pay a dividend.
45.98M
Market cap
166.00x
Current P/E
7.16x
Forward P/E
IDXG chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Diagnostics & Research
Industry
Interpace Biosciences, Inc. is a U. S.-based company specializing in advanced molecular diagnostic tests, bioinformatics, and pathology services, primarily focused on assessing cancer risk. Among its key offerings is PancraGEN, a comprehensive genomic test for pancreatic cysts and solid lesions within the pancreaticobiliary system.
Similar securities
Based on sector and market capitalization
Report issue